| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/02/2002 | EP1165057A2 Endodontic fibers and methods of use therefor |
| 01/02/2002 | EP1165056A2 A process for the microencapsulation of medicaments |
| 01/02/2002 | EP1165055A2 Pharmaceutical composition containing an extrusion additive |
| 01/02/2002 | EP1165054A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/02/2002 | EP1165053A1 Fast-dispersing dosage forms containing fish gelatin |
| 01/02/2002 | EP1165052A1 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic and use and method for obtaining same |
| 01/02/2002 | EP1165051A1 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| 01/02/2002 | EP1165050A1 Methods for fine powder formation |
| 01/02/2002 | EP1165049A2 Agglomerates by crystallisation |
| 01/02/2002 | EP1165048A1 Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| 01/02/2002 | EP1165047A1 Fusogenic lipids and vesicles |
| 01/02/2002 | EP1165046A1 Propofol compositions containing preservative additives |
| 01/02/2002 | EP1165045A1 Propofol formulation with enhanced microbial characteristics |
| 01/02/2002 | EP1165044A2 High potency dihydroergotamine compositions |
| 01/02/2002 | EP1165043A1 Drinkable pharmaceutical solution |
| 01/02/2002 | EP1165042A1 Drinkable ibuprofen pharmaceutical suspension |
| 01/02/2002 | EP1165041A1 Antimicrobial wipes which provide improved immediate germ reduction |
| 01/02/2002 | EP1165031A1 Resorcinol composition |
| 01/02/2002 | EP1165017A1 Liquid dispersion polymer compositions, their preparation and their use |
| 01/02/2002 | EP1164996A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 01/02/2002 | EP1164994A1 Opioid agonist in a fast dispersing dosage form |
| 01/02/2002 | EP1164991A1 Gels formed by the interaction of poly(aldehyde) with various substances |
| 01/02/2002 | EP1164987A1 Improved conjunctival inserts for topical delivery of medication or lubrication |
| 01/02/2002 | EP1164844A1 Compositions for aquatic contained in a microparticulate or nanoparticulate vector |
| 01/02/2002 | EP1121930A4 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases |
| 01/02/2002 | EP1112053A4 Organosilicone compositions for personal care |
| 01/02/2002 | EP1051157B1 Controlled release delivery of peptide or protein |
| 01/02/2002 | EP1011635A4 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 01/02/2002 | EP0954314B1 Dosage forms for ameliorating male erectile dysfunction |
| 01/02/2002 | EP0934342B1 Composition containing chitosan |
| 01/02/2002 | EP0854703B1 Composition for treating keratinous material, including at least one silicone-grafted polymer and at least one thickening polymer or copolymer of (meth)acrylamide or a (meth)acrylamide derivative, and uses thereof |
| 01/02/2002 | EP0835100B1 Topical aciclovir preparation |
| 01/02/2002 | EP0600079B1 Oral 1alpha-hydroxyprevitamin d |
| 01/02/2002 | CN2468489Y Bone setting medical plaster |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329590A Therapeutic product and its use |
| 01/02/2002 | CN1329507A Topical compositions comprising ascomycins |
| 01/02/2002 | CN1329502A Pharmaceutical compositions containing insulin |
| 01/02/2002 | CN1329501A Therapeutic agent for suppression of snoring noises |
| 01/02/2002 | CN1329500A Anti-dandruff composition comprising antifungal polypeptide |
| 01/02/2002 | CN1329496A Methods and cmpositions for prevention of tolerance to medications |
| 01/02/2002 | CN1329494A Micronized eplerenone compositions |
| 01/02/2002 | CN1329488A Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 01/02/2002 | CN1329487A Dispersible compositions containing L-dopaethyl ester |
| 01/02/2002 | CN1329486A Method for producing agglomerates comprising core-shell structure |
| 01/02/2002 | CN1329485A Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/02/2002 | CN1329478A Capsules |
| 01/02/2002 | CN1328844A Liquid Chinese medicine for curing hemorrhoid complicated by anal fistula |
| 01/02/2002 | CN1328843A Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method |
| 01/02/2002 | CN1328840A Medicated bag for curing tussis |
| 01/02/2002 | CN1328836A Ointment for curing hemorrhoids |
| 01/02/2002 | CN1328830A Pueraria root soluble granules |
| 01/02/2002 | CN1328828A Plaster for curing external hemorrhoids |
| 01/02/2002 | CN1328827A Nanometer silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
| 01/02/2002 | CN1328825A Ass-hide glue cutting process |
| 01/02/2002 | CN1328819A Nanometer silver antimicrobial inflammation-relieving film for curing gynecopathy and its production process |
| 01/02/2002 | CN1328811A Method for producing solid oral preparation form with continuous released active components |
| 01/02/2002 | CN1077073C Improved storage wrap material |
| 01/02/2002 | CN1076972C Base agent and drug composition thereof which are taken through skin |
| 01/02/2002 | CN1076965C Cleaning tissues treated with water -in-lipid emulsion |
| 01/02/2002 | CN1076964C Coated capsule type medicinal preparation capable of releasing at lower part of alimentary canal |
| 01/02/2002 | CN1076963C Stable W/O/W triple emulsion, composition containing said emulsion and its use |
| 01/01/2002 | US6335388 Composition comprising mixture of prolamine, plant polar lipid, at least one polyalcohol in hydro-alcoholic solution and active agent, wherein composition forms substantially homogeneous dispersion or film with skin adhesive properties |
| 01/01/2002 | US6335383 Microdispersions for coating surgical devices |
| 01/01/2002 | US6335356 Method of treating a patient by parenteral administration of a lipophilic compound |
| 01/01/2002 | US6335335 Prolonged-action eye drop |
| 01/01/2002 | US6335320 Method of treating fibrotic conditions |
| 01/01/2002 | US6335316 Method for administering acylated insulin |
| 01/01/2002 | US6335199 Gene therapy |
| 01/01/2002 | US6335194 Antisense modulation of survivin expression |
| 01/01/2002 | US6335037 Cosmetic comprising spherical hydrophobic fine silica particles |
| 01/01/2002 | US6335036 2-phenyl-1,2-benzisoselenazol-3(2h)-one and hydroxypropyl cellulose |
| 01/01/2002 | US6335035 Hyaluronic acid salts blended with hydroxyethylcellulosea and hydroxypropylcellulose; analgesics |
| 01/01/2002 | US6335034 Topical drug preparations |
| 01/01/2002 | US6335033 Melt-extrusion multiparticulates |
| 01/01/2002 | US6335032 Orally administrable solid dosage form |
| 01/01/2002 | US6335031 (s)-n-ethyl-3-(1-dimethylamino)ethyl)-n-methyl-phenyl-carbamat salt form and antioxidant; alzheimer's disease therapy |
| 01/01/2002 | US6335030 Dextromethorphan, 3-methoxy-17-methyl-9a,13a,14a-morphanin, salts, prodrugs metabolites and carriers |
| 01/01/2002 | US6335029 Polymeric coatings for controlled delivery of active agents |
| 01/01/2002 | US6335028 Implantable particles for urinary incontinence |
| 01/01/2002 | US6335024 Cosmetic and dermatological compositions containing aminoalcohol derivatives containing a urea functional group and uses thereof |
| 01/01/2002 | US6335022 Nanoemulsion based on oxyethylenated or non-oxyethylenated sorbitan fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 01/01/2002 | US6335012 Delivering lytic enzyme able to digest cell wall of bacteria and toothpaste, oral wash, chewing gum, and lozenge; anticaries agents |
| 01/01/2002 | US6334999 Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs |
| 01/01/2002 | US6334968 Forming polysaccharide gel(from alginates solution) freezing, adding cross-linker(strontium chloride, calcium gluconate, calcium chloride);biodegradation, mechanical properties; time release agents |
| 01/01/2002 | US6334856 Microneedle devices and methods of manufacture and use thereof |
| 01/01/2002 | CA2188691C Composition containing a polymeric system and use of said system |
| 01/01/2002 | CA2173318C Preparation of medical devices by solid free-form fabrication methods |
| 01/01/2002 | CA2171939C Novel method of progesterone delivery and affect thereof |
| 01/01/2002 | CA2094267C Use of fatty alcohol based composition for preparing emulsions, method of preparing emulsions and emulsions so obtained |
| 01/01/2002 | CA2085490C Processes for the manufacture of enriched pitches and carbon fibers |
| 01/01/2002 | CA2048544C Intravascular embolizing agent containing angiogenesis-inhibiting substance |
| 01/01/2002 | CA2036707C Improved coated medicaments and apparatus and methods for making the same |
| 12/27/2001 | WO2001098348A2 Regulation of cellproliferation and differentiation using topically applied peptides |
| 12/27/2001 | WO2001098335A2 Transgenic algae for delivering antigens to an animal |
| 12/27/2001 | WO2001098329A1 Polyhydroxy glycopeptide derivatives |
| 12/27/2001 | WO2001098328A2 Glycopeptide phosphonate derivatives |
| 12/27/2001 | WO2001098327A2 Glycopeptide carboxy-saccharide derivatives |
| 12/27/2001 | WO2001098326A2 Glycopeptide disulfide and thioester derivatives |
| 12/27/2001 | WO2001098321A1 Inhibition of human squamous cell carcinoma in vivo by egfr antisense rna |